论文信息 - Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022 - 字舞流文

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

Andrew L. Phillips | Lauren E. W. Olsho | Krystal S. Jovel | E. Bedrick | K. Hegmann | John T Jones | A. Fowlkes | K. Ellingson | A. Caban-Martinez | L. Gerald | K. Krupp | P. Madhivanan | J. Burgess | M. Thiese | Andrew L Phillips | A. Naleway | M. Gaglani | M. Thompson | J. Gerald | Zuha Jeddy | Brandon Poe | S. Beitel | Josephine Mak | K. Lutrick | K. Dunnigan | Natasha Solle | Laura J. Edwards | L. Grant | Lisa Gwynn | Sana M. Khan | Sarang K. Yoon | A. Lowe | Young M. Yoo | M. Berry | J. Burns | Lindsay B LeClair | Ramona P Rai | Clare Mathenge | Julie Mayo Lamberte | H. McLeland-Wieser | Leah Odame-Bamfo | B. Sokol | James Hollister | Jezahel S Ochoa | Felipe A Pubillones | Joanna Lopez | S. Rose | Deanna E. Fleary | Harmony L. Tyner | Patrick Rivers | Maria V. Ferraris | N. Solle | Lindsay LeClair